The motivation behind the work is a genuine public health problem. Raw meat-based diets, particularly those fed to pets, retain their natural nutritional profile and palatability but carry inherent zoonotic risks in the shared living environments of animals and their owners. Regulatory bodies including the U.S. Food and Drug Administration and the American Veterinary Medical Association have warned about pathogen-contaminated raw pet food, yet conventional thermal sterilization destroys the very qualities that make raw diets appealing. High hydrostatic pressure offers an alternative: it transmits pressure uniformly through a product regardless of shape or size, works on sealed packages to prevent recontamination, has regulatory approval in major markets, and preserves heat-sensitive nutrients and flavors.

The study’s experimental design was deliberately broader than most previous work. Earlier investigations typically tested a narrow pressure range of 200 to 400 megapascals and examined either microbial safety or physicochemical quality in isolation. Here, pork samples were artificially contaminated with multiple strains of Escherichia coli, Bacillus cereus, Salmonella Typhimurium, Listeria monocytogenes, and Staphylococcus aureus, reaching initial populations of roughly 10^5 to 10^8 colony-forming units per gram. Vacuum-sealed samples were then treated in an industrial high-pressure sterilizer maintained at 21 degrees Celsius internally, creating a graduated pressure-time matrix that had never been systematically evaluated for raw pork intended for pet food.

The microbial results were striking and strongly pressure-dependent. Treatment at 500 megapascals for fifteen minutes produced the most pronounced inactivation across all organisms, and Salmonella Typhimurium and Listeria monocytogenes were reduced to below the detection limit during subsequent refrigerated storage. The mechanism is physical rather than chemical: compressive forces deform cell membranes and walls, increase membrane permeability, disrupt intracellular ion balance, dissociate ribosomes, and inactivate enzymes, ultimately collapsing cellular homeostasis. Pressures above 100 megapascals alter the phospholipid bilayer itself, impairing nutrient transport and energy metabolism.

Not every pathogen surrendered equally easily, however, and the species-specific patterns proved scientifically revealing. Although gram-positive bacteria are generally considered more pressure-resistant thanks to their thicker peptidoglycan layers, Listeria monocytogenes, despite being gram-positive, was completely eliminated under the harshest conditions, while Staphylococcus aureus showed the highest resistance of all organisms tested. Staphylococcus possesses a thick, highly cross-linked peptidoglycan layer of roughly 20 to 40 nanometers, and in the most intense treatment group its counts actually increased during storage, suggesting recovery and regrowth from sublethal injury. Bacillus cereus and E. coli also remained detectable under most conditions, with Bacillus spores protected by a multilayered structure that distributes pressure and maintains a dehydrated core stabilized by calcium-dipicolinic acid complexes.

The physicochemical consequences of pressure treatment were equally systematic. As pressure and holding time increased, water-holding capacity, shear force, and pH all rose above control values, while moisture and protein contents increased and fat and ash decreased. The researchers attribute these shifts to pressure-induced denaturation and reorganization of myofibrillar proteins. The non-covalent bonds that maintain protein structure, including ionic bonds, hydrogen bonds, and hydrophobic interactions, are voluminous and unstable under pressure, so when secondary and tertiary structures collapse, myosin partially unravels and exposes polar and charged groups that bind water. The resulting compact protein network traps moisture in a gel-like matrix but also cross-links myosin aggregates, making crack propagation difficult and increasing mechanical strength, which explains the higher shear force.

Color changes followed a nuanced pattern tied to the pigment myoglobin and to light-scattering physics. Lightness increased with pressure and time, redness peaked in the 300 megapascal groups before falling again at 500 megapascals, and yellowness was highest in the 500 megapascal, five-minute group. Previous research has shown that dramatic pressure-induced color changes in meat generally appear only above roughly 400 to 600 megapascals, leaving color largely preserved at lower intensities. The observed paleness here is attributed more to protein denaturation and microstructural changes that enhance light scattering than to straightforward myoglobin oxidation, a combined effect rather than a single pigment transformation.

Oxidation and spoilage chemistry told a two-sided story. Thiobarbituric acid reactive substances, a marker of lipid oxidation, rose with pressure and time, reaching their highest values in the 500 megapascal, fifteen-minute group and climbing further during storage. Pressures between 300 and 700 megapascals disrupt phospholipid membranes and expose lipids to oxygen and pro-oxidants, while structural changes in heme proteins can release iron ions that catalyze oxidative chain reactions. In contrast, volatile basic nitrogen, an indicator of protein decomposition and spoilage, was suppressed by treatment, with the 500 megapascal, five-minute group showing the lowest increase rate during storage at just 13.24 percent compared with 111.72 percent in the mildest group. Microbial inactivation and pressure-induced enzyme inactivation both limit the production of ammonia and volatile amines.

Correlation analysis tied the whole picture together. Pressure and holding time correlated negatively with all tested microorganisms, redness, and volatile basic nitrogen, while water-holding capacity, shear force, pH, lightness, yellowness, and lipid oxidation correlated positively, all consistent with cumulative pressure-induced effects on membranes, myofibrils, myoglobin, and enzymes. The authors conclude that while high hydrostatic pressure effectively inactivated Salmonella and Listeria, enhanced water retention, and suppressed spoilage markers, it also produced a paler appearance, increased lipid oxidation, and failed to achieve complete microbial elimination, with pressure-tolerant organisms surviving or recovering.

The practical takeaway is that pressure treatment should not be deployed as a stand-alone solution. The researchers recommend integrated hurdle strategies, combining pressure with salt addition, antimicrobial agents, optimized packaging, and strict refrigerated storage management, to push microbial safety further while preserving quality. For a food industry increasingly interested in minimally processed products, the study provides something rare: a complete pressure-time map showing exactly where pathogen reduction ends and quality degradation begins, at least for raw pork. As demand for raw pet food and clean-label meats grows, that map may prove one of the most useful tools yet for producers navigating the delicate balance between safety and freshness.

Subject of Research: Effects of high hydrostatic pressure processing on microbial inactivation and physicochemical quality of raw pork

Article Title: Application of high hydrostatic pressure on the microbial and physicochemical characteristics of pork

Article References: Baek, U.-B., & Kim, H.-Y. (2026). Application of high hydrostatic pressure on the microbial and physicochemical characteristics of pork. Food Science of Animal Resources, 46(1), Article 73. https://doi.org/10.1007/s44463-026-00091-8

Image Credits: AI Generated

DOI: 10.1007/s44463-026-00091-8

Keywords: high hydrostatic pressure, food safety, pork, microbial inactivation, non-thermal processing, Salmonella, Listeria monocytogenes, lipid oxidation, myofibrillar protein, water-holding capacity, raw pet food, food science

The study, published in Food Science of Animal Resources, set out to optimize high-pressure processing, or HPP, for wild deer loins. HPP is a non-thermal preservation technology that subjects vacuum-packed food to uniform hydrostatic pressure, inactivating microorganisms and enzymes at low temperatures without the sensory and nutritional damage caused by sterilization or pasteurization. The technique is already used commercially on juices, guacamole and deli meats, but its effects depend heavily on the food matrix. Moderate pressures between 300 and 400 megapascals achieve partial microbial reduction while better preserving raw meat quality, whereas pressures above 500 megapascals kill more microbes but can wreck colour and texture. Finding the sweet spot for venison was the goal of Beatriz García-Béjar, Almudena Soriano and colleagues at the University of Castilla-La Mancha, working with the Castilla y León Agricultural Technological Institute.

The raw material came from 16 male Iberian red deer shot during montería hunts in the province of Ciudad Real at the end of the hunting season. Each animal was eviscerated and inspected by a veterinarian in the field, hung in a refrigerated truck and aged for two days at 4 to 5 degrees Celsius before the loins — the longissimus thoracis et lumborum muscles — were extracted. Each left loin was halved and vacuum-packed, with one half kept as an untreated control and the other processed on an industrial Hiperbaric Wave 6000/135 unit, a 135-litre vessel calibrated annually and fitted with alarms that interrupt the cycle if pressure or temperature drifts. Treatments were applied on the fifth day after death, and all analyses were completed one week after slaughter, giving a realistic picture of how the technology would perform in a commercial workflow.

In the optimization phase, the team tested six pressure-time combinations: 350, 450 and 550 megapascals, each for either 3 or 6 minutes, with biological replicates from different animals. Initial bacterial counts hovered around 6 log colony-forming units per gram. The heaviest treatment, 550 megapascals, delivered the biggest microbial kill, reducing viable mesophilic aerobic bacteria by more than 2 log units — roughly 99.5 percent. Treatments at 350 and 450 megapascals still achieved reductions greater than 1 log unit, corresponding to about 94.9 to 96.8 percent. Interestingly, processing time on its own and the pressure-time interaction had no statistically significant effect on bacterial reduction, suggesting that pressure, not duration, is the dominant lever. But the price of brute force became obvious the moment the researchers looked at the meat itself.

Colour is the single most important quality cue for raw meat, and HPP left a visible fingerprint. Control loins bloomed to a bright red after 45 minutes of exposure to oxygen, as myoglobin converted to oxymyoglobin. Treated samples turned a pinkish-brown, and the effect intensified with pressure. Instrumental measurements confirmed the shift: lightness and yellowness values rose across all treatments, while redness dropped significantly from the 450 megapascal, 6-minute condition onward. The mechanism is well understood — myoglobin begins to denature at pressures of 400 megapascals and above, altering the way muscle absorbs and reflects light. A trained sensory panel of four experts with more than 25 years of experience each, working under ISO consensus-profiling protocols, agreed: aroma and tenderness were unaffected, but adhesiveness increased and red colour faded, with the worst damage at 550 megapascals, where colour intensity fell by two to three points on a three-point scale.

Based on this trade-off, the researchers selected 350 megapascals for 6 minutes as the best compromise and put it through a tougher test. Four loins from different animals were deliberately chosen because their high microbial loads reflected particularly poor hygiene during field handling — a worst-case scenario, though not fully representative of the wider population. The results were striking. Mesophilic aerobic bacteria fell by 99.97 percent, from about 7.9 to 4.4 log CFU per gram. Enterobacteriaceae dropped by 99.98 percent, and Escherichia coli by 99.99 percent, plunging from 7.8 to 2.1 log CFU per gram. Staphylococcus spp. counts were cut by 99.99 percent, and neither Salmonella spp. nor Listeria spp. could be detected in treated samples, with absence confirmed in 25-gram portions. Notably, no Staphylococcus aureus was found in any sample, treated or not.

The microbiology behind these numbers is revealing. Gram-negative bacteria such as E. coli and the Enterobacteriaceae are known to be more pressure-sensitive than gram-positive species, whose cross-linked peptidoglycan cell walls provide structural armour. Yet even the gram-positive Staphylococcus spp. in this study collapsed under treatment, a sensitivity the authors attribute to variability in baro-resistance and to the stage of the cell cycle. Rod-shaped bacteria also tend to be more vulnerable than spherical cocci, which helps explain the dramatic elimination of Listeria. The data also hinted that the treatment works harder on dirtier meat: samples starting at 8 log CFU per gram lost 99.97 percent of their bacteria, while cleaner samples starting at 6.1 log CFU per gram lost 94.9 percent. For a sector where carcass contamination ranges from below 2 to over 6 log CFU per square centimetre depending on field practices, that scalability matters.

Crucially, the gentler treatment left the meat’s chemistry largely intact. pH rose only slightly and non-significantly, moisture content was unchanged at around 76 percent, and cooking losses were statistically identical between treated and control loins at roughly 28 to 31 percent. Drip loss during 48 hours of refrigerated storage was actually lower in the pressurized meat, indicating improved water-holding capacity — a potential commercial bonus. The sensory story, however, had a twist. In a triangle test with 14 expert tasters following ISO 4120 protocols, panellists could reliably distinguish raw treated venison from raw controls, citing colour and tactile texture in every case. But once the loins were grilled to an internal temperature of 72 degrees Celsius, the differences vanished: the panel could no longer tell treated from untreated meat. Thermal denaturation of muscle proteins and surface browning reactions appear to homogenize whatever HPP changed, meaning consumers would never notice on the plate.

To understand what pressure actually does to muscle, the team turned to cryo-scanning electron microscopy, freezing samples in liquid nitrogen and imaging them with a field-emission microscope. The treated loins showed clearly defined separation between myofibrils — a subtle structural loosening that likely underlies the increased adhesiveness the panellists noted and the textural differences detected in raw samples. Similar disruption of sarcomere continuity has been reported in myofibrils exposed to 300 megapascals. The authors are careful to frame the work as preliminary: only four loins were used in the validation assay, and larger datasets are needed to confirm the findings and to test whether HPP extends shelf life. Still, the message is compelling. A 6-minute treatment at 350 megapascals can eliminate Salmonella and Listeria and slash bacterial loads by up to 99.99 percent in heavily contaminated wild venison, while leaving pH, moisture and cooked eating quality untouched. For a growing game meat industry operating outside the hygiene controls of conventional slaughterhouses, that combination of safety and subtlety could be exactly what it takes to bring wild deer from the hunting field to the supermarket shelf — and finally to the fork — with confidence.

Subject of Research: Optimization of high-pressure processing conditions for microbial reduction and quality preservation in wild venison

Article Title: Preliminary optimization and quality assessment of high-pressure processing for venison preservation

Article References: García-Béjar, B., González-Fernández, J. L., Alarcón, M., Delgado, B., Peinado, C., & Soriano, A. (2026). Preliminary optimization and quality assessment of high-pressure processing for venison preservation. Food Science of Animal Resources, 46(1), Article 109. https://doi.org/10.1007/s44463-026-00117-1

Image Credits: AI Generated

DOI: 10.1007/s44463-026-00117-1

Keywords: high-pressure processing, venison, game meat, food safety, microbial reduction, Salmonella, Listeria, E. coli, meat colour, sensory analysis, cryo-SEM, water-holding capacity

The research team set out to answer a question that has practical consequences for the pet food industry: how much pressure is enough to kill dangerous microbes, and how much is too much before the meat itself begins to suffer? They treated raw beef loin, a primary ingredient in raw pet food formulations, at pressures of 0.1, 100, 300, and 500 megapascals for holding times of 5 to 15 minutes, then tracked both microbial survival and a battery of physicochemical properties over two weeks of refrigerated storage. Five pathogens were inoculated onto the meat: Salmonella Typhimurium, Escherichia coli, Staphylococcus aureus, Listeria monocytogenes, and Bacillus cereus. The samples were vacuum-packed and processed within two hours of inoculation to minimize any changes in microbial populations before treatment.

The microbial results followed a clear pressure-time hierarchy. At 100 megapascals, the inactivation effect was limited, consistent with reversible cellular responses rather than irreversible damage; membranes may become permeabilized without sufficient disruption of intracellular structures, allowing microorganisms to recover. As pressure increased, structural disruption of cell membranes and protein denaturation progressed, leading to irreversible cellular damage. The most striking result came at 500 megapascals for 15 minutes, where Salmonella Typhimurium was reduced to below the detection limit of one log colony-forming unit per gram and was never re-detected during the entire two-week storage period. The other pathogens were not completely eliminated, but they showed substantial reductions with limited regrowth.

The differential survival of the pathogens tells a fascinating story about cell architecture. Gram-positive bacteria such as Listeria monocytogenes and Staphylococcus aureus possess thicker peptidoglycan layers than their gram-negative counterparts, conferring greater pressure resistance. Among all the organisms tested, Staphylococcus aureus proved the toughest, and the authors attribute this to a suite of defensive features: the antioxidant pigment staphyloxanthin, a high content of branched-chain fatty acids in the cell membrane, extensive secondary cross-linking of peptidoglycan, and teichoic acids that stabilize the cell wall against deformation. Immediately after the 500-megapascal, 15-minute treatment, E. coli, Listeria, Staphylococcus, and Bacillus were reduced by 77.47, 77.58, 48.77, and 71.83 percent respectively compared with the control, and over the storage period the reductions reached 59.46, 68.35, 53.39, and 92.08 percent.

Bacillus cereus added another layer of complexity because of its spore-forming ability. Rather than being killed directly, pressures above 50 megapascals stimulate germinant receptors and SpoVA channels within the spores, triggering the release of calcium and calcium-dipicolinic acid and raising the water content of the spore core. Once germinated, the spores convert into vegetative cells, losing their pressure resistance and becoming more susceptible to oxidative stress and DNA damage. This supports what the authors describe as a germination-inactivation sequence rather than direct spore lethality, a nuance that matters greatly for shelf-stable product design.

On the quality side, the picture was more mixed. Proximate composition, meaning moisture, protein, fat, and ash content, remained unchanged across all treatments, largely because vacuum packaging prevented drip loss, the main route by which pressure treatment can alter bulk nutritional composition. pH was similarly stable throughout processing and storage, which the researchers link to the suppression of microbial metabolism and endogenous enzymatic activity, the two main drivers of postmortem biochemical change. However, higher pressures and longer holding times increased lightness, yellowness, shear force, water-holding capacity, and thiobarbituric acid reactive substances, a marker of lipid oxidation, while redness declined. The 500-megapascal, 15-minute treatment raised lightness by 36.95 percent compared with the control, producing a visibly paler product.

One of the most intriguing findings is a paradox in texture. The highest pressure-time combination produced both the greatest water-holding capacity and the highest shear force, meaning the meat held more water yet became tougher. The authors explain this through pressure-induced protein aggregation: dissociated myofibrillar proteins interact through exposed sulfhydryl groups and hydrophobic residues, forming gel-like networks that immobilize water within a mechanically rigid matrix. Water retention, in other words, does not equal tenderness under high pressure. Meanwhile, color changes were governed by non-linear interactions between structural light scattering and myoglobin redox chemistry; at an intermediate 300 megapascals, metmyoglobin-reducing enzymes remain active enough to partially preserve redness, whereas 500 megapascals inactivates those enzymatic defenses.

Oxidation and spoilage chemistry also responded to pressure in opposing directions. Lipid oxidation, measured as TBARS, increased with both pressure intensity and storage time, driven by the release of non-heme iron when myoglobin’s porphyrin structure is destroyed; that iron reacts with hydrogen peroxide to generate hydroxyl radicals that attack lipids. Volatile basic nitrogen, an indicator of protein deterioration, moved the opposite way, falling significantly at 500 megapascals because high pressure suppresses both the microbes and the proteolytic enzymes, including calpains and cathepsins, that would otherwise degrade muscle proteins. Yet even here, storage mattered: VBN values climbed in all groups by week two, suggesting residual enzymatic activity persists after treatment.

The study’s practical conclusion is that processing intensity must be optimized rather than maximized. The 500-megapascal, 15-minute condition delivered the strongest antimicrobial effect but also the worst quality outcomes, including tougher texture, more lipid oxidation, and color deterioration. Moderate conditions around 300 megapascals for 15 minutes achieved substantial microbial reduction while better preserving the attributes that determine palatability, which matters because companion animals are sensitive to texture and appearance as well as to microbial hazards. The authors acknowledge limitations, notably the absence of sensory evaluation, and propose that future work employ electronic nose and tongue instruments and gas chromatography-based volatile analysis, along with digestibility trials, to establish biologically relevant processing windows. For an industry racing to make raw diets safe without making them sterile and unappetizing, this study provides exactly the kind of pressure-time framework needed to find that balance.

Subject of Research: Effects of high-pressure processing on microbial safety and physicochemical quality of raw beef loin for pet food

Article Title: Analyses of the microbial safety and physicochemical characteristics of beef loin treated with high-pressure

Article References: Baek, U.-B., & Kim, H.-Y. (2026). Analyses of the microbial safety and physicochemical characteristics of beef loin treated with high-pressure. Food Science of Animal Resources, 46(1), Article 74. https://doi.org/10.1007/s44463-026-00081-w

Image Credits: AI Generated

DOI: 10.1007/s44463-026-00081-w

Keywords: high-pressure processing, raw pet food, beef loin, foodborne pathogens, Salmonella, Listeria monocytogenes, Staphylococcus aureus, microbial inactivation, lipid oxidation, meat quality, non-thermal sterilization, food safety

The appeal of bacteria as anti-cancer agents rests on a quirk of tumor physiology. Solid tumors are riddled with regions of hypoxia, necrosis, and poor perfusion — conditions that starve conventional chemotherapies of access but that many anaerobic and facultative anaerobic bacteria actively seek out. Once there, engineered strains can colonize selectively, produce therapeutic payloads in situ, remodel the tumor microenvironment, and recruit the immune system against the malignancy. This is a capability no small molecule or antibody can replicate: a living factory that navigates to its target, senses its surroundings, and manufactures its drug on site.

The review organizes the genetic control layer around three classes of regulatory circuits. Hypoxia-responsive promoters switch payload expression on only in the oxygen-poor depths of a tumor, sparing healthy, well-oxygenated tissue. Quorum-sensing circuits tie gene expression to bacterial population density, so that therapeutic output scales with the degree of colonization rather than with the administered dose alone. Externally responsive systems, meanwhile, give clinicians an external handle — for example, near-infrared light or high-intensity focused ultrasound can trigger payload release at a chosen time and place, converting an autonomous microbe into a remotely controllable device. Together, these gating strategies address one of the field’s oldest problems: keeping a potent payload silent until the bacterium has arrived where it is needed.

But the authors are careful to emphasize that bacterial activity cuts both ways. Engineered microbes act on four compartments of the tumor at once — malignant cells, stromal cells, immune cells, and the resident microbiome — and every one of those interactions can be therapeutic or counterproductive. A strain that lyses tumor cells may also provoke inflammatory toxicity; a payload that converts a prodrug such as 5-fluorocytosine into the cytotoxic 5-fluorouracil locally may leak into circulation; a bacterium that activates antitumor immunity may also, in some contexts, recruit immunosuppressive cells. The review’s framework therefore insists that designers map these effects explicitly rather than assume that colonization equals benefit.

The clinical record to date is instructive precisely because it is mixed. Attenuated Salmonella strains have been tested intravenously and shown the ability to seed tumors, but heterogeneous colonization and dose-limiting toxicity have constrained their use. Clostridium spores exploit the anaerobic necrotic core of tumors but leave the oxygenated rim untouched, which is why combination strategies with radiotherapy or chemotherapy have been explored. Listeria-based platforms have been pursued for their potent ability to stimulate cell-mediated immunity, while Bifidobacterium offers an inherently safe, non-pathogenic chassis for payload delivery. E. coli Nissle 1917, a probiotic strain with a long safety history, has emerged as a particularly versatile chassis, and intratumoral injection — as in the approved use of Bacille Calmette–Guérin for non-muscle-invasive bladder cancer — demonstrates that local bacterial therapy can already be standard of care when the indication is chosen correctly.

From these experiences, the authors extract a set of design rules that read like a checklist for the next generation of trials. Route selection matters: intravenous delivery demands strains that survive blood-borne clearance, while intratumoral delivery trades systemic reach for control and tolerability. Quantitative colonization assessment — measuring colony-forming units or imaging bacterial presence — must replace anecdotal evidence that a strain has homed to the tumor. Payload gating must be tight enough that measurable bacterial products appear only where intended. Treatment sequencing must consider how bacteria interact with checkpoint inhibitors, chemotherapy, and radiotherapy, since the immune context created by one modality can determine whether the next succeeds. Rescue planning — antibiotics, in effect a kill switch at the level of the whole patient — must be defined before dosing begins. And indication choice should favor tumors whose ecology is permissive: hypoxic, immunologically accessible, and anatomically reachable.

The review also positions bacterial platforms alongside oncolytic viruses, the other major class of living therapeutics, arguing that the two are complementary rather than competing. Oncolytic viruses such as talimogene laherparepvec are optimized for direct tumor lysis and antigen release, while bacteria offer larger payload capacity, deeper penetration into hypoxic and necrotic regions that viruses find hostile, and a distinct immunostimulatory profile driven by pathogen-associated molecular patterns engaging Toll-like receptors. A rational combination might use a virus to inflame the tumor and a bacterium to colonize its necrotic core and sustain payload production — a sequencing question the framework explicitly addresses.

Manufacturing and pharmacology emerge as the quiet determinants of whether any of this reaches patients. Living products resist the standard chemistry, manufacturing, and controls logic of the pharmaceutical industry: batch-to-batch consistency, stability, and product release testing all become harder when the drug is alive and dividing. The authors stress that reproducible development strategies, good manufacturing practice frameworks adapted to living organisms, and honest pharmacodynamic modeling — how many bacteria arrive, how long they persist, and how much payload they produce — are as important to translation as any genetic innovation. Uncertain pharmacology and host clearance, they note, have limited clinical translation as much as any scientific failure.

The conclusion the authors reach is a deliberate reorientation of the field’s ambitions. Rather than maximizing circuit complexity — building bacteria with ever more layers of sensing, logic, and actuation — the priority should be simplicity that can be measured, controlled, and reproduced. A strain expressing a single well-characterized payload under a validated hypoxia-responsive promoter, delivered by a route matched to the tumor, quantitatively tracked, and paired with a clear rescue plan, is more likely to advance the field than a marvel of genetic engineering whose behavior in a patient cannot be predicted or verified. In that sense, the resurrection of bacterial cancer therapy is less a technological triumph than a discipline: the tumors, the microbes, and the clinic must all agree before the therapy works.

For a field that has oscillated between enthusiasm and abandonment since the days of Coley’s toxins, the framework offers something rare — a sober synthesis that treats past clinical disappointments as data rather than dead ends. With synthetic biology now supplying the control layer that earlier generations lacked, and with early studies across six bacterial genera providing the empirical grounding, engineered bacteria may finally be positioned to take their place among living therapeutics, not as a replacement for existing oncology tools but as a complement designed around the one environment cancer drugs have never fully reached: the hypoxic, necrotic, immunologically complicated interior of a solid tumor.

Subject of Research: Synthetic biology approaches to engineered bacterial cancer therapeutics

Article Title: Synthetic biology resurrects bacterial cancer therapy

Article References: Regmi, M., Kong, B., Xiong, Y., Liu, S., Liu, J., Xia, Q., & Yang, C. (2026). Synthetic biology resurrects bacterial cancer therapy. BMC Medicine. https://doi.org/10.1186/s12916-026-05272-2

Image Credits: AI Generated

DOI: 10.1186/s12916-026-05272-2

Keywords: synthetic biology, bacterial cancer therapy, living therapeutics, tumor microenvironment, tumor microbiome, Salmonella, E. coli Nissle, oncolytic viruses, hypoxia-responsive circuits, quorum sensing, translational design, BMC Medicine

The device, called a Bacteria-Releasing Mucoadhesive Sheet, or BRMS, was developed by Jihun Lee, Sana Ashraf, and colleagues working with Sukho Park at institutions including the Korea Institute of Science and Technology and Daegu Gyeongbuk Institute of Science and Technology. Its design responds to three formidable barriers that defeat conventional oral drug delivery in the gut: the acidic environment of the stomach, the sticky mucus layer that coats the intestinal wall, and the tight junctions that seal the epithelial lining. Rather than swallowing a pill and hoping it survives the journey, clinicians would deploy the BRMS directly onto a tumor using an endoscope or a magnetically steered capsule robot, keeping the sheet sealed and dry until the moment of release.

The sheet’s architecture is a study in layered functional engineering. An outer unrolling layer made of poly(ethylene glycol) dimethacrylate swells dramatically when it contacts intestinal fluid, generating a bending moment that causes the rolled sheet to unfurl within roughly 100 seconds and drape itself conformally over curved mucosal surfaces. Beneath it sits a guard layer of tri(ethylene glycol) dimethacrylate, a nearly impermeable polymer that blocks bacteria from escaping into the gut lumen and enforces strictly one-way release toward the tumor. The therapeutic layer itself is split into two zones: a peripheral ring of alginate and skim milk that provides powerful mucoadhesion, and a central reservoir containing freeze-dried, genetically engineered Salmonella together with the sugar L-arabinose.

The mucoadhesion is not a minor detail — it is the linchpin of the entire strategy. In the turbulent environment of the intestine, where peristaltic waves and continuous fluid flow scour the mucosal surface, free bacteria or drug particles are swept away within minutes. Quantitative tests on porcine small intestinal tissue showed that after two minutes of contact, the BRMS required a detachment force of 0.544 newtons, roughly four times greater than a gelatin control sheet commonly used in drug delivery research. The alginate-rich peripheral region achieves this grip through abundant carboxyl and hydroxyl groups that form dense hydrogen-bonding networks with mucin, the glycoprotein that gives mucus its adhesive character. Skim milk, meanwhile, serves as a cryoprotectant that shields bacterial cell membranes from ice-crystal damage during freeze-drying, allowing the bacteria to be stored dry and revived on demand.

The therapeutic payload is as sophisticated as the carrier. The researchers used an attenuated Salmonella Typhimurium strain, engineered with deletions in the aroA, aroD, rcsB, and asd genes to reduce virulence, and equipped it with a plasmid that fuses the anticancer peptide VC1 to FlgM, a protein naturally exported through the flagellar type III secretion system. VC1, also known as α-conotoxin Vc1.1, is a 16-amino-acid peptide originally discovered in the venom of the marine cone snail Conus victoriae. It blocks the α9α10 nicotinic acetylcholine receptor, a receptor implicated in cancer cell proliferation, survival, and migration. When the sheet hydrates at the target site, the co-encapsulated L-arabinose switches on the bacterial secretion machinery, and the Salmonella begin pumping out VC1 into the tumor’s extracellular space.

What sets this system apart from passive drug formulations is what happens next. Conventional nanoparticles and small-molecule drugs rely on diffusion, a process that stalls in the dense extracellular matrix and elevated interstitial fluid pressure of solid tumors. In confocal microscopy experiments on three-dimensional CT-26 colon cancer spheroids roughly 400 micrometers across, a doxorubicin-loaded control sheet delivered its payload only to the outer rim of the tumor model, with signal fading to nearly nothing beyond about 21 percent of the spheroid’s radius. The Salmonella released from the BRMS, by contrast, distributed throughout the entire spheroid, propelled by their flagella and guided by their natural preference for the hypoxic, immunosuppressed conditions found in tumor cores. In a Transwell assay simulating mucus barriers and fluid wash-out, the sheet achieved bacterial penetration roughly 130-fold higher than a free bacterial suspension of the same dose.

The cytotoxicity results under physiologically mimetic conditions were equally striking. When CT-26 colon cancer cells were separated from treatments by a motility agar barrier and subjected to a wash-out step, neither the doxorubicin-loaded sheet nor the free Salmonella suspension produced meaningful cell death — both were defeated by the physical barrier and fluid flow. The fully functional BRMS carrying VC1-induced Salmonella, however, killed the largest fraction of cancer cells, combining the bacteria’s intrinsic oncolytic activity and nutrient competition with the anticancer action of locally secreted VC1. The effect extended across species: supernatants from VC1-secreting bacteria significantly reduced viability not only in mouse CT-26 cells but also in human SW480 and HT-29 colorectal cancer lines.

Perhaps the most clinically compelling demonstrations came from the delivery experiments. Using a standard commercial colonoscope fitted with a soft Ecoflex cap that stays sealed during navigation and opens only when forceps push the sheet out, the team deployed BRMS units onto porcine intestinal tissue mounted in a 3D-printed phantom. The sheets released, self-unrolled, and adhered conformally to the mucosa within view of the endoscopic camera, and a separate test inside an intact, uncut porcine intestinal lumen confirmed the approach works under realistic anatomical conditions. The researchers also loaded four rolled sheets into a custom magnetically actuated capsule robot, steered it wirelessly using a six-coil electromagnetic actuation system, and sequentially deposited all four units at spatially distinct target sites — a capability that could allow multiple lesions to be treated in a single procedure.

In vivo, the platform delivered its most dramatic result. In BALB/c mice bearing subcutaneous CT-26 tumors, mice implanted with the fully activated BRMS — bacteria plus L-arabinose induction — showed progressive tumor regression rather than mere growth delay, ending the two-week study with markedly smaller tumors than every control group. Crucially, mice that received the same dose of VC1-secreting Salmonella as a free suspension showed tumor growth indistinguishable from untreated controls, a direct demonstration that the therapeutic benefit came from the sheet’s ability to retain bacteria at the lesion, not from the bacteria alone. Histology revealed extensive necrosis and elevated apoptotic cell populations in treated tumors, and no significant body weight loss or systemic toxicity appeared in any group.

The authors are candid about the hurdles that remain before the BRMS reaches patients. The L-arabinose inducer loaded within the sheet proved insufficient for autonomous high-level VC1 secretion in vitro, forcing daily intraperitoneal injections in the mouse study — an approach that would undermine the convenience of localized therapy in the clinic. Future iterations may engineer bacteria that secrete VC1 constitutively or respond to tumor-specific cues such as hypoxia or acidity, or deliver the inducer orally. The in vivo model also placed tumors under the skin rather than in the gut, so orthotopic studies in large animals will be needed to validate unrolling, adhesion, and bacterial kinetics in a real gastrointestinal environment. Biosafety, too, demands attention: although the attenuated strain caused no observable adverse effects, infection risk in immunocompromised patients may ultimately favor swapping Salmonella for clinically validated probiotic strains such as engineered E. coli Nissle 1917. Even so, the BRMS stands as a vivid example of what happens when synthetic biology, materials science, and surgical robotics converge — a living drug factory, glued to a tumor, swimming medicine into places no molecule could reach on its own.

Subject of Research: A mucoadhesive bacteria-releasing sheet for localized, penetrative therapy of gastrointestinal cancer using engineered Salmonella

Article Title: A bacteria-releasing mucoadhesive sheet for localized delivery and penetrative therapy of gastrointestinal cancer

Article References: Lee, J., Ashraf, S., Kim, E., Lee, H.-J., Park, J., Jeon, H. J., Suh, S., & Park, S. (2026). A bacteria-releasing mucoadhesive sheet for localized delivery and penetrative therapy of gastrointestinal cancer. Materials Today Bio, 41, Article 103710. https://doi.org/10.1016/j.mtbio.2026.103710

Image Credits: AI Generated

DOI: 10.1016/j.mtbio.2026.103710

Keywords: gastrointestinal cancer, Salmonella, mucoadhesive sheet, drug delivery, bacterial therapy, VC1 conotoxin, capsule robot, endoscopy, tumor penetration, biotechnology, oncology, hydrogel

The technology addresses a persistent and underappreciated problem in livestock production. Rice husk, an abundant by-product of rice milling, is widely used as poultry bedding because it is cheap, lightweight, and absorbs moisture well. But during storage and use, bedding accumulates organic matter, fecal residues, and moisture that support microbial growth. Contaminated bedding can act as a long-term environmental reservoir for foodborne pathogens, facilitating transmission between production cycles and throughout the poultry supply chain. Conventional sanitation relies on chemical disinfectants such as quaternary ammonium compounds, aldehyde-based treatments, and oxidizing agents, yet these often penetrate bulk biomass poorly, work unevenly in porous substrates, and lose effectiveness under high organic loading, while raising concerns about residues, worker exposure, and environmental impact.

The new system, described in the journal Cleaner Engineering and Technology, is a trailer-mounted, mobile processing platform designed for continuous on-site operation. Its core components include an insulated sanitization chamber, a screw-assisted biomass transport mechanism that lifts and cascades rice husk particles through the treatment zone, an LPG-fueled gas burner generating hot air at 350 to 400 degrees Celsius, a hot-air mixing chamber, forced-air and recirculation blowers, and a cyclone dust separation unit. The screw-assisted cascading design is central to the system’s performance: by continuously lifting and redistributing particles, it repeatedly exposes fresh surfaces to the heated airflow, minimizing localized cold spots and thermal dead zones within the porous biomass bed.

A key engineering innovation is the airflow recirculation architecture. Rather than exhausting heated air after a single pass, the system captures hot air exiting the chamber, passes it through cyclone separators to remove suspended dust, and redirects it back into the heating circuit. This recirculation loop achieved an efficiency of approximately 86.7 percent, substantially improving thermal retention, stabilizing chamber temperature under transient loading, and reducing fuel consumption. Under steady-state conditions, the sanitization chamber held temperatures of roughly 115 to 125 degrees Celsius while rice husk exited at 95 to 100 degrees Celsius, with chamber temperature variation held to about plus or minus 2.1 degrees Celsius.

Residence time proved to be a critical operating variable. By tuning screw rotational frequency between 50 and 60 hertz, the researchers achieved residence times of 15 to 17 minutes, which they identified as the optimal window balancing microbial inactivation against throughput. At these settings the system processed 2.0 to 2.5 tonnes of rice husk per hour with thermal utilization efficiency peaking near 87.6 percent. Shorter residence times below 10 minutes risked ineffective sanitization, while longer exposures reduced productivity without meaningful gains. Statistical analysis confirmed that both temperature and residence time significantly influenced microbial reduction, with their interaction significant at p less than 0.01.

The microbiological validation was unusually rigorous for an industrial study. Throughout three years of routine monitoring, approximately 67 samples per month were collected from production lots of about 15 tonnes each, and formal annual validations compared 50 samples before treatment with 50 after. All analyses were performed at an ISO/IEC 17025-accredited laboratory, using selective enrichment, culture on Xylose Lysine Deoxycholate agar, and confirmatory identification by MALDI-TOF mass spectrometry. Under optimized conditions, contamination frequency fell from 16 percent to 4 percent, an estimated 75 percent reduction in positive detections. In controlled laboratory experiments, log reductions of total bacterial count reached 6.2 to 6.4 log CFU per gram at 120 to 125 degrees Celsius, corresponding to inactivation efficiencies above 99.999 percent, and Salmonella was not detected under any tested condition.

Perhaps the most instructive finding concerned moisture. Feedstock water content emerged as a dominant constraint on performance, contributing an estimated 18.6 percent of the relative influence on lethality. At moisture levels of 8 to 11 percent, the system achieved log reductions of about 6.3, but at 18 to 20 percent moisture the reduction fell to roughly 2.7 log, a level the authors classified as ineffective. The explanation is thermodynamic: water evaporation consumes latent heat, diverting thermal energy away from microbial destruction and buffering the biomass temperature. Field validation during rainy conditions confirmed the pattern, with positive detections rising to 9 percent at high moisture and 14 percent when high moisture was combined with shortened residence time. The researchers argue that industrial thermal sanitization must therefore be governed by integrated heat-and-moisture frameworks rather than temperature-only criteria, and they recommend real-time moisture sensing and adaptive residence-time control as future upgrades.

The economics are compelling. Total treatment cost was estimated at 0.0083 US dollars per kilogram of rice husk, compared with 0.014 to 0.021 dollars for conventional centralized chemical sterilization, an operating cost reduction of roughly 40 to 60 percent and a benefit-cost ratio of 4.6. LPG consumption averaged 8.3 kilograms per tonne of treated biomass, translating to a fuel cost of about 0.0052 dollars per kilogram. The savings arose from multiple vectors: complete elimination of disinfectant procurement, which alone accounted for 38.4 percent of total savings; removal of dedicated chemical storage warehouses; simplified single-stage logistics replacing multi-stage transport to centralized facilities; and reduced transportation emissions from on-site processing. Over three years, cumulative savings exceeded 0.30 million US dollars, averaging about 100,000 dollars annually.

From a sustainability standpoint, the system embodies cleaner production and circular economy principles. By using thermal energy as the sole sanitizing agent, it removes chemical residues from bedding that might otherwise accumulate in soils when spent litter is applied as fertilizer, and it eliminates occupational exposure to formaldehyde and related compounds. The life-cycle analysis, conducted through a life-cycle thinking approach rather than a formal ISO 14040/14044 assessment, attributed 34.8 percent of sustainability benefits to chemical elimination, 26.5 percent to biomass reuse and valorization, and 11.6 percent to avoided transportation. The technology effectively upcycles a low-value agricultural residue into a standardized sanitary product, closing a resource loop that links rice milling, poultry farming, and eventual nutrient recycling through spent bedding.

The authors are careful to note limitations. The microbiological outcomes reflect the tested operating conditions and should not be read as evidence of complete pathogen elimination under all field scenarios, and the sustainability percentages are relative indicators rather than quantified greenhouse gas reductions. Future work will pursue a full cradle-to-grave life cycle assessment, quantitative microbial inactivation modeling using D-value and z-value kinetics, computational fluid dynamics optimization of the reactor, and predictive process control. Still, the demonstrated combination of scale, reliability, and economics marks a significant step. A system that processes nearly 8,000 tonnes of abrasive, silica-rich biomass over three years with greater than 95 percent availability shows that continuous thermal sanitization has moved beyond the pilot stage, offering poultry producers a practical blueprint for biosecurity that is simultaneously cleaner, cheaper, and more circular than the chemical status quo.

Subject of Research: Industrial-scale continuous thermal sanitization of rice husk bedding for chemical-free poultry biosecurity

Article Title: Industrial-scale continuous thermal sanitization of rice husk bedding for cleaner poultry production: Resource valorization, biosecurity improvement, and sustainability assessment

Article References: Sangpradit, K., Thoetrattanakiat, S., Sookyoo, W., Intarasuk, A., & Samseemoung, G. (2026). Industrial-scale continuous thermal sanitization of rice husk bedding for cleaner poultry production: Resource valorization, biosecurity improvement, and sustainability assessment. Cleaner Engineering and Technology, 34, Article 101304. https://doi.org/10.1016/j.clet.2026.101304

Image Credits: AI Generated

DOI: 10.1016/j.clet.2026.101304

Keywords: rice husk, poultry bedding, thermal sanitization, biosecurity, cleaner production, circular economy, pathogen inactivation, agricultural waste valorization, hot-air heating, Salmonella, LPG energy efficiency, sustainable livestock production

The rationale behind the study rests on a persistent mismatch in the probiotic marketplace. Although Bifidobacterium longum is a well-characterized Gram-positive, anaerobic bacterium with a long history of safe use in humans, holding Qualified Presumption of Safety status from the European Food Safety Authority and Generally Recognized as Safe classification from the U.S. Food and Drug Administration, the vast majority of commercial strains were isolated from infant feces, adult intestines, and breast milk. Host specificity matters. Differences in gut anatomy, physiology, resident microbial communities, and diet between humans and livestock can undermine the adhesion capacity and survival of human-derived strains when they are administered to animals, limiting their efficacy in the very settings where they are increasingly needed.

Previous attempts to deploy human strains in animals have produced mixed results. An infant-derived B. longum strain reduced Campylobacter jejuni counts in poultry without improving growth performance, and piglets given a probiotic mixture containing an infant-derived B. longum subspecies alongside Lactobacillus rhamnosus failed to recover feed intake and body weight after infection with enterotoxigenic Escherichia coli. These observations led the research team to hypothesize that B. longum strains recovered from healthy calves would carry host-specific traits that enhance their survival and persistence in the bovine gut, and they set out to test this idea with an unusually comprehensive combination of whole-genome sequencing and in vitro functional assays.

Working under University of Florida Institutional Animal Care and Use Committee approval, the team collected rectal fecal samples from 47 healthy pre-weaning dairy calves between three and 28 days of age. Using Bifidus Selective Medium under anaerobic conditions, they recovered 225 presumptive isolates, from which 16 Bifidobacterium candidates were selected for whole-genome sequencing on an Illumina NextSeq platform. Rigorous taxonomic classification confirmed 12 of these as B. longum, alongside three Bifidobacterium pseudocatenulatum isolates and one Ligilactobacillus salivarius. Core-genome phylogenetic analysis revealed that the 12 B. longum isolates, while genetically close overall, split into two distinct clades, and no identical genomes were detected, underscoring the strain-level diversity circulating within a single herd. Intriguingly, all strains isolated from nine-day-old calves grouped within the same clade, hinting at age-related colonization patterns during early life.

Genome annotation painted a picture of bacteria well equipped for gastrointestinal life. Every strain carried the atpA-H gene cluster encoding the ATP synthase complex, which maintains intracellular pH homeostasis under acidic conditions, a fundamental requirement for surviving gastric transit. Roughly twenty loci tied to exopolysaccharide biosynthesis and biofilm assembly were distributed across the genomes, including multiple epsF variants showing strain-specific sequence variation, glycosyltransferases that influence adhesion and surface colonization. Conserved ribonucleotide reductase components including nrdH, nrdI, and nrdE2 support genome stability under oxidative stress, while ATP-dependent chaperone-protease systems such as clpX, clpB, and clpP, together with heat shock proteins dnaK, dnaJ, and the groL/groS chaperonin system, provide the protein quality control machinery needed to weather environmental shocks. Critically, screening with the BAGEL4 platform detected no known bacteriocin biosynthetic gene clusters, a finding that would later shape interpretation of the antimicrobial results.

To place the calf isolates in broader evolutionary context, the researchers constructed a core-genome phylogeny incorporating 792 publicly available B. longum genomes, of which 759 originated from humans. The resulting tree showed clear host-associated clustering: livestock strains, including the calf isolates, cows, and pigs, grouped together in a distinct clade, while companion animal and food-derived strains were more interspersed among human genomes. The 12 calf-derived isolates formed their own tight cluster within the livestock-associated branch, providing compelling genomic evidence of host-associated diversification. This lineage-level divergence supports the central premise of the study, that probiotic strains should ideally be sourced from the host species they are meant to benefit.

Functional testing then put the isolates through a gauntlet of gastrointestinal stressors. In simulated gastric fluid containing pepsin at pH 3, all strains except two maintained greater than 10 percent viability after two hours, and every strain held viable counts above 10^7 CFU/mL. Under postprandial acid conditions at pH 3, all isolates exceeded 10 percent survival, with eight strains retaining more than half their viable cells after two hours. Bile salt challenge at 0.2 percent concentration, which mimics the antimicrobial environment of the small intestine, left all strains above 10^7 CFU/mL, consistent with the conserved bile salt hydrolase gene bsh found in every genome. Lysozyme, an innate immune enzyme that cleaves the peptidoglycan of Gram-positive bacteria, failed to meaningfully reduce viability in any isolate. Only osmotic stress at 2 and 3 percent sodium chloride proved broadly inhibitory. Three strains, KCJ2K3504, KCJ2K3532, and KCJ2K3574, consistently outperformed their relatives across every tolerance assay, marking them as standouts for survival during oral administration and gut transit.

Colonization potential was assessed through four complementary phenotypes. Cell surface hydrophobicity, measured by adhesion to xylene, exceeded 50 percent in eight strains, with two isolates reaching values above 95 percent, a trait linked to initial contact with mucosal surfaces. Mucin adhesion, quantified in mucin-coated microplates, was measurable in all strains except one, confirming capacity to engage the intestinal mucus layer that serves as the primary interface between host and microbe. Every strain formed biofilms under mucus-associated conditions, and auto-aggregation assays revealed strain-dependent variation, with one isolate, KCJ2K3577, aggregating at a rate of 94 percent within five hours while the others ranged from 45 to 66.2 percent. Together these properties suggest the isolates could establish persistent populations in the calf gut, forming microcolonies that resist mechanical flushing and competitive exclusion of invaders.

The antagonism results were the study’s most striking. Cell-free supernatants from all 12 B. longum isolates produced clear inhibition zones against both Salmonella enterica serovar Typhimurium and serovar Dublin in agar well diffusion assays, and this activity was significantly reduced when supernatants were neutralized to pH 7, indicating that the inhibition was primarily pH-dependent and driven by organic acid production rather than bacteriocins, consistent with the absence of bacteriocin gene clusters. Co-culture competition assays delivered even more dramatic outcomes: three strains completely suppressed S. Typhimurium growth over 48 hours, while seven strains completely inhibited S. Dublin. Given that Typhimurium represents a broad-host-range pathogen and Dublin is cattle-adapted and invasive, the breadth of inhibition across both serovars carries real significance for preharvest food safety.

Safety screening rounded out the evaluation. Antimicrobial resistance gene analysis against the CARD database detected no resistance genes in two isolates, KCJ2K3532 and KCJ2K3574, while the remaining strains carried mostly intrinsic or genus-associated determinants such as rpoB and ileS, predominantly chromosomal and considered low risk for horizontal transfer. Integrating all the evidence, the authors conclude that KCJ2K3532 and KCJ2K3574, which combine strong Salmonella inhibition, robust stress tolerance, colonization traits, and clean genomic safety profiles, are the most promising candidates for in vivo validation. The team cautions that the safety assessment was computational and that future work must include phenotypic safety testing, host response studies, colonization trials in calves, and characterization of the antimicrobial compounds themselves. Still, the study makes a persuasive case that the next generation of livestock probiotics will come not from human microbiome catalogs but from the guts of the animals they are meant to protect.

Subject of Research: Probiotic characterization of calf-derived Bifidobacterium longum and their inhibition of Salmonella

Article Title: Host-associated Bifidobacterium longum exhibit gastrointestinal resilience and antagonistic activity against Salmonella serovars

Article References: Host-associated Bifidobacterium longum exhibit gastrointestinal resilience and antagonistic activity against Salmonella serovars. (n.d.). https://doi.org/10.1016/j.crfs.2026.101580

Image Credits: AI Generated

DOI: 10.1016/j.crfs.2026.101580

Keywords: Bifidobacterium longum, probiotics, dairy calves, Salmonella, gut microbiome, livestock health, whole-genome sequencing, antimicrobial resistance genes, organic acids, host specificity, gastrointestinal resilience, food safety

The research, led by Wanqiu Huang and Jinjing Ni together with colleagues at Shanghai Jiao Tong University School of Medicine and collaborating institutions, focuses on a histone modification known as H2BK16ac. This tag refers to the acetylation of lysine 16 on histone H2B, one of the proteins around which DNA is wound. Acetylation of histone tails generally loosens the chromatin structure, making genes more accessible to the transcription machinery. When the researchers examined macrophages infected with Salmonella, they found that this acetylation mark on H2BK16 was actively removed. The deacetylation was carried out by two enzymes, HDAC1 and HDAC3, which strip acetyl groups from histones and thereby tighten chromatin at specific genomic locations.

The consequence of this chromatin tightening was the transcriptional silencing of a gene called Id3, which encodes Inhibitor of Differentiation 3. ID3 is a member of the helix-loop-helix protein family and is known to influence the behavior of various immune cells, but its role in macrophage-mediated antibacterial defense had not been clearly defined. The new study shows that when Salmonella drives H2BK16 deacetylation through HDAC1 and HDAC3, the Id3 gene is switched off, and macrophages lose an important layer of antimicrobial capacity. This finding places ID3 at the center of an infection-induced epigenetic pathway that directly shapes how macrophages respond to bacterial challenge.

To establish that ID3 genuinely strengthens macrophage defenses, the team performed both loss-of-function and gain-of-function experiments. When ID3 was removed or reduced, macrophages showed a weakened inflammatory response and diminished antimicrobial activity. Conversely, when ID3 was increased, macrophages displayed enhanced antibacterial function. These results demonstrate that ID3 is not a passive bystander in the infection response but an active contributor to the macrophage arsenal against invading bacteria.

The mechanistic heart of the study lies in how ID3 controls the expression of another protein, Z-DNA binding protein 1, commonly abbreviated as ZBP1. ZBP1 is a sensor that recognizes certain nucleic acid structures and participates in immune signaling. The researchers discovered that a transcription factor called E2A binds to the ZBP1 gene and represses its transcription. ID3 counteracts this repression by sequestering E2A, effectively pulling it away from the ZBP1 promoter. With E2A occupied by ID3, the ZBP1 gene is free to be transcribed, and macrophages maintain robust ZBP1 expression. This sequestration mechanism reveals a precise molecular handoff in which ID3 acts as a decoy to relieve transcriptional braking on an antimicrobial effector gene.

The in vivo relevance of this circuit was tested in mice engineered to lack Id3 specifically in myeloid cells, the lineage that includes macrophages. When these myeloid-specific Id3-deficient mice were infected with Salmonella, they carried higher bacterial burdens and suffered greater pathological damage than control animals. This outcome confirms that the ID3-ZBP1 axis is not merely a cell-culture curiosity but a functional component of antibacterial immunity in living organisms. The data suggest that the integrity of this epigenetic pathway determines how effectively the host can contain systemic bacterial spread.

Perhaps the most translational aspect of the study involves a pharmacological intervention. The researchers treated infected mice with MS-275, an inhibitor of histone deacetylases that targets HDAC1 among other class I enzymes. Administration of MS-275 restored the H2BK16ac mark, reactivated the Id3 gene, and thereby rebuilt the ID3-ZBP1 signaling axis. In practical terms, the drug reversed the epigenetic silencing that Salmonella had imposed on macrophages. Mice receiving this treatment showed amelioration of systemic Salmonella infection, demonstrating that pharmacologically reopening the chromatin at Id3 can translate into meaningful protection against bacterial disease.

These findings carry several implications for the broader field of infection biology. First, they establish that pathogens do not merely evade immune detection; they actively reshape the epigenetic landscape of host immune cells to disable specific defense genes. The Salmonella-driven deacetylation of H2BK16 represents a concrete example of how bacterial infection can hijack the host’s own chromatin-modifying enzymes to silence protective transcriptional programs. Second, the study identifies ID3 as a previously underappreciated regulator of macrophage immunity, bridging histone acetylation status to the expression of a nucleic acid sensor involved in antimicrobial signaling. Third, the demonstration that an HDAC inhibitor can restore this axis in vivo suggests a therapeutic window in which epigenetic drugs, originally developed for oncology, might be repurposed as adjunct treatments for severe bacterial infections.

The work also raises questions that will likely drive future research. It remains to be seen whether other pathogens employ similar strategies to silence Id3 or related immune regulators through histone deacetylation. The precise kinetics of HDAC1 and HDAC3 recruitment to the Id3 locus during infection, and whether additional chromatin marks cooperate with H2BK16ac in this process, are areas that warrant deeper investigation. Furthermore, because ZBP1 has been implicated in antiviral as well as antibacterial pathways, the ID3-E2A-ZBP1 circuit could have relevance beyond Salmonella, potentially influencing how macrophages respond to a wider spectrum of infectious threats. The study by Huang, Ni, and colleagues thus opens a new line of inquiry into how epigenetic therapies might bolster innate immunity at a time when antibiotic resistance continues to limit conventional treatment options.

Subject of Research: Infection-driven epigenetic regulation of macrophage innate immunity through the H2BK16ac-ID3-ZBP1 axis

Article Title: Infection-driven epigenetics modulate macrophage innate immunity through the H2BK16ac-ID3-ZBP1 axis

Article References: Huang, W., Ni, J., Tang, H., Chen, Y., Zhou, T., Yu, J., Wang, Z., Wen, B., Yan, H., Wang, C., Tao, J., Lu, J., Zhao, G.-P., Wang, D., & Yao, Y.-F. (2026). Infection-driven epigenetics modulate macrophage innate immunity through the H2BK16ac-ID3-ZBP1 axis. Cellular and Molecular Life Sciences. https://doi.org/10.1007/s00018-026-06432-6

Image Credits: AI Generated

DOI: 10.1007/s00018-026-06432-6

Keywords: macrophage, innate immunity, epigenetics, histone acetylation, H2BK16ac, ID3, ZBP1, Salmonella, HDAC1, HDAC3, E2A, MS-275

The raw feeding movement traces its modern popularity to the 1993 publication of Ian Billinghurst’s book Give Your Dog a Bone, which argued that dogs thrive on bones and raw meat reminiscent of an ancestral canine diet. Today the category encompasses home-prepared BARF recipes, prey-model regimens, commercial frozen and chilled complete diets, freeze-dried products, premixes combined with raw meat, and raw meaty bones. The review stresses that these categories are not interchangeable. They differ in nutrient formulation, ingredient traceability, pathogen-control procedures, storage requirements and owner handling, and studies that lump all raw diets into a single exposure may obscure important variation in risk.

On the nutritional front, the review finds that adequacy is genuinely product-specific. In one analytical study of 33 preprepared raw dog foods labelled as complete, every single product had at least three mineral values outside the FEDIAF reference range. Selenium fell below the minimum recommendation in all 33 products, zinc, manganese and copper were frequently below recommended intakes, 45.5 percent of products exceeded the maximum calcium recommendation, and 57.6 percent exceeded the maximum iodine value. The authors caution that these deviations identify quality-control concerns within the sampled products but do not by themselves establish clinical deficiency or toxicity in the dogs consuming them, and the findings should not be generalized to every commercial raw product on the market.

Home-prepared raw diets fare less well in the literature. Analyses of published recipes, drawn from a broader body of work on home-prepared diets, have identified frequent deficiencies in calcium, zinc, copper, vitamin D, vitamin E and choline. Ingredient rotation, a common owner strategy, does not guarantee nutritional completeness, because adequacy depends on quantitative formulation and nutrient bioavailability rather than variety alone. Puppies are especially vulnerable to inappropriate calcium and phosphorus concentrations, and excessive liver or unbalanced supplementation can produce vitamin and trace-mineral excesses. Professional guidance therefore supports formulation and periodic review by a veterinarian with advanced nutrition training, particularly for growth, disease management or long-term exclusive feeding.

Where raw diets do show consistent short-term effects is in digestibility and faecal characteristics. Controlled studies have repeatedly reported higher apparent total-tract digestibility of protein and fat in raw, mildly cooked or human-grade fresh diets compared with extruded kibble, along with smaller, firmer stools and reproducible changes in faecal microbiota and fermentation products. Yet the review urges technical caution in interpreting these numbers. The diets being compared rarely differ only in processing; they typically vary simultaneously in ingredients, fat, fibre, starch, moisture and energy density, so higher digestibility coefficients cannot be attributed to the absence of heat treatment alone. Human-grade mildly cooked diets can produce similar effects, and no universally accepted healthy canine microbiome signature exists against which these compositional differences could be judged beneficial or harmful. Crucially, long-term clinical superiority of raw feeding over nutritionally complete conventional diets has not been demonstrated.

The microbiological picture is where the evidence is strongest and most troubling. Because raw meat receives no thermal kill step, contamination can persist from slaughter through processing, transport and household handling. Surveillance studies across Europe and the Americas have repeatedly detected Salmonella, Campylobacter, Listeria monocytogenes, Shiga toxin-producing Escherichia coli, Yersinia enterocolitica and other enteric bacteria in commercial raw pet foods. The largest recent United Kingdom retail survey tested 380 frozen raw products collected between March 2023 and February 2024. In the dog-food subset, Salmonella was detected in 24.2 percent of samples, Campylobacter in 14.4 percent, culture-confirmed STEC in 13.4 percent and MRSA in roughly 10 percent, while ESBL- or AmpC-producing E. coli were found in 21.5 percent of the dog-food samples tested for that outcome. Across the full dataset, 28.7 percent of products exceeded statutory microbiological criteria.

The review is equally clear that freezing and freeze-drying are not reliable microbial kill steps. Viable bacteria have been recovered from commercial freeze-dried raw products, and available evidence indicates that drying may reduce rather than eradicate contamination. Parasites add another layer of concern, including Toxoplasma gondii, Sarcocystis species, Neospora caninum and, depending on geographic origin and offal source, Echinococcus. An Italian observational study found that dogs reported to consume raw meat regularly had nearly threefold higher odds of Toxoplasma seropositivity, supporting exposure plausibility even though raw meat cannot be confirmed as the sole source. Domestic freezers may not achieve validated time-temperature combinations uniformly, so parasite control requires source-specific rather than generic assumptions about freezing.

Dogs fed raw diets can shed enteric pathogens without showing any clinical signs, creating a household exposure pathway through food preparation, contaminated bowls and surfaces, faeces and close contact. Multiple observational studies have linked raw feeding to increased faecal carriage of Salmonella and antimicrobial-resistant E. coli, including third-generation cephalosporin-resistant and multidrug-resistant strains in United Kingdom dog populations. Whole-genome sequencing has identified closely related resistant Enterobacterales in companion animals and their household members, supporting recent sharing or a common source, although genomic relatedness alone cannot establish the direction of transmission. Documented human outbreaks underscore that severe outcomes are possible: a cluster of Shiga toxin-producing E. coli O157:H7 infections was linked to raw tripe pet food, and Canadian authorities investigated an outbreak of extensively drug-resistant Salmonella associated with raw pet food and cattle contact. The review notes, however, that outbreak reports establish possibility and severity rather than the population-level burden of raw-pet-food-associated human disease.

On the environmental side, the evidence is the least raw-diet-specific. Life-cycle assessments of pet food generally show that impacts are driven principally by the type and quantity of animal-derived ingredients, with ruminant and human-edible meat dominating land use and greenhouse-gas emissions. A recent United Kingdom analysis of 996 dog foods, including 34 raw products, estimated a greater than 65-fold range in greenhouse-gas intensity across products, with prime-meat content an important driver. Frozen products require cold-chain energy during distribution and home storage, whereas freeze-drying demands substantial manufacturing energy but reduces transport mass and avoids frozen storage, and few matched assessments have quantified these trade-offs. The authors conclude that a poultry or by-product-based raw food may compare favourably with a beef-rich premium kibble, so the raw format itself cannot be assumed intrinsically more impactful.

The review’s overarching message is that raw meat-based diets warrant product-specific and household-specific risk assessment rather than categorical judgement. For owners who choose to continue raw feeding, veterinary counselling should prioritize nutritionally complete formulation appropriate for life stage, manufacturer quality assurance, validated pathogen-reduction processes such as high-pressure processing that reduce but do not eliminate risk, uninterrupted cold chains, strict hygiene including bowl cleaning and handwashing, prompt faeces disposal, and explicit consideration of household vulnerability. Households containing infants, pregnant individuals, older adults or immunocompromised people face a lower margin of safety, and raw feeding may be inappropriate when their exposure cannot be reliably prevented. The authors call for adequately powered prospective cohorts, batch-level surveillance that distinguishes raw diet categories, whole-genome-sequencing source-attribution studies, validation of pathogen-reduction technologies, and matched life-cycle assessments before the long-term benefits and risks of raw feeding can be compared with high certainty.

Subject of Research: Nutritional adequacy, microbiological safety, antimicrobial resistance and environmental sustainability of raw meat-based diets for dogs within a One Health framework

Article Title: Raw meat based diets for dogs and their nutritional and One Health implications

Article References: Tufarelli, V., & Bozzo, G. (2026). Raw meat based diets for dogs and their nutritional and One Health implications. Discover Animals, 3(1), Article 84. https://doi.org/10.1007/s44338-026-00249-0

Image Credits: AI Generated

DOI: 10.1007/s44338-026-00249-0

Keywords: raw meat-based diets, dog nutrition, One Health, Salmonella, antimicrobial resistance, zoonotic pathogens, pet food safety, BARF diet, foodborne illness, life cycle assessment, Toxoplasma gondii, veterinary nutrition